SCHEMBL6312975

SCHEMBL6312975

CC(C)C(O)CN(Cc1cccc(C(F)(F)C(F)(F)F)c1)c1cccc(OCc2cccc(C(F)(F)F)c2)c1

nearest known ligand 0.62

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CETP P11597 16/20 0.62
MAOB P27338 1/20 0.48
NR4A2 P43354 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6313531 0.92 CETP (0.62) CETP
SCHEMBL995086 0.89 CETP (0.78) CETP
SCHEMBL995184 0.89 CETP (0.78) CETP
SCHEMBL6312432 0.89 CETP (0.80) CETP
SCHEMBL6305583 0.88 CETP (0.58) CETPMAOBNR4A2
SCHEMBL6304923 0.88 CETP (0.60) CETPMAOB
SCHEMBL6307357 0.87 CETP (0.56) CETPMAOBNR4A2
SCHEMBL6305097 0.87 CETP (0.61) CETPNR4A2
SCHEMBL6311438 0.86 CETP (0.55) CETPMAOBNR4A2
SCHEMBL6312277 0.86 CETP (0.60) CETPMAOBNR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6861561-B2 Substituted aromatic policyclic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity G. D. SEARLE & CO. (US) 2005-03-01 US claimed
US-20030225088-A1 Substituted aromatic policyclic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity G.D. SEARLE & CO. (US) 2003-12-04 US claimed
US-6482862-B1 Method of using substituted N-benzyl-N-phenyl aminoalcohols for inhibiting cholesteryl ester transfer protein activity G.D. SEARLE & CO. 2002-11-19 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030225088-A1 Substituted aromatic policyclic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity CETP, PCTP, MTTP CETP 1/4885MAOB 1526/4885NR4A2 1830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.